PLSE - NASDAQ

Pulse Biosciences, Inc.

PLSE·NASDAQ

$27.64

+11%

HealthcareMedical - Instruments & Supplies

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.91B

EPS-1.0800

P/E Ratio-25.59

Earnings Date08/11/2026

plse

Cost of Revenue

Last Annual Value

1.61M

3-Year CAGR

-49%

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Pulse Biosciences, Inc. Competitors Analysis of Cost of Revenue

PLSE · NASDAQ

Company	Cost of Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
Pulse Biosciences, Inc. NASDAQ:PLSE	1.61M	10.1%	-3.9%	9.2%
NovoCure Limited NASDAQ:NVCR	166.88M	9.2%	7.8%	13.7%
Nektar Therapeutics NASDAQ:NKTR	0.00	N/A	N/A	N/A
Kestra Medical Technologies, Ltd. NASDAQ:KMTS	35.60M	24.9%	N/A	N/A
OPKO Health, Inc. NASDAQ:OPK	478.83M	-4.2%	-16.7%	-2.4%
Dianthus Therapeutics, Inc. NASDAQ:DNTH	0.00	N/A	N/A	N/A
Beta Bionics, Inc. NASDAQ:BBNX	44.71M	98.8%	N/A	N/A
Atai Beckley Inc. NASDAQ:ATAI	1.01M	46.9%	84.8%	N/A
LifeMD, Inc. NASDAQ:LFMD	39.29M	27.6%	16.9%	35.1%
STAAR Surgical Company NASDAQ:STAA	62.55M	-3.6%	3.8%	10.0%

Pulse Biosciences, Inc. Fair Value Envelope

PLSE · NASDAQ

Our analysis suggests that PLSE has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $27.6372, this represents a potential HIDDEN relative to our calculated worth for Pulse Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $27.6372

Related Guides

Blog Categories

Continue your PLSE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.